Hahn-Schickard produces PCR rapid tests for SARS-CoV-2
Within a very short time, Hahn-Schickard, together with the Freiburg-based medical technology company Spindiag GmbH and supported by the University of Freiburg, developed the PCR-based corona rapid test based on an existing test system for hospital germs
The new test system just released to the market in November 2020 as an approved medical product by Sindiag GmbH is safe to operate, time-saving and designed for mobile use. Hahn-Schickard has established a multi-shift operation for producing the test cartridges, thereby successfully proving its quick and purposeful reaction time to current economic requirements. Spindiag emerged in 2016 from the cooperation between Hahn-Schickard and the IMTEK Laboratory for MEMS Applications at the University of Freiburg. The company is certified according to EN ISO 13485.